About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The VHIR Infectious Diseases research group is made up of medical professionals, with healthcare and clinical or basic translational research activities; of Biomedicine dedicated to basic research; and Nursing, with activities to support clinical research.
The group's lines of research are mainly focused on four areas:
Infections related to immunosuppression. Includes infectious diseases related to immunocompromised patients, solid organ or hematopoietic stem cell transplant recipients and recipients of biological therapies.
Sexually transmitted diseases, including HIV infection and other highly prevalent infections in our country (syphilis, gonorrhea, lymphogranuloma venere or infections caused by the human papillomavirus).
Infections related to health care, with special emphasis on those difficult to treat (cardiovascular infections or infections related to prosthetic materials) or caused by multi-resistant pathogens (MDRO) or affecting vulnerable populations.
Global Health and Tropical Diseases with special emphasis on prevalent diseases in our environment that affect the immigrant or displaced population.
PMID: 33444752 Journal: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES Year: 2021 Reference: Int J Infect Dis. 2021 Jun;107:300-310. doi: 10.1016/j.ijid.2021.01.019. Epub 2021 Jan 12. Impact factor: 3.623 Publication type: Paper in international publication Authors: Marcolino, Milena S, Ziegelmann, Patricia K, Souza-Silva, Maira V R, do Nascimento, Israel J Borges, Oliveira, Luana M, Monteiro, Luanna S, Sales, Thais L S, Martins, Karina P M P, Etges, Ana Paula B S, Molina, Israel et al. DOI: 10.1016/j.ijid.2021.01.019
PMID: 33422078 Journal: MALARIA JOURNAL Year: 2021 Reference: Malar J. 2021 Jan 9;20(1):35. doi: 10.1186/s12936-021-03580-x. Impact factor: 2.979 Publication type: Paper in international publication Authors: Omer, Samia, Franco-Jarava, Clara, Noureldien, Ali, Omer, Mona, Abdelrahim, Mutasim, Molina, Israel, Adam, Ishag et al. DOI: 10.1186/s12936-021-03580-x
PMID: 33404892 Journal: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES Year: 2021 Reference: Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1137-1148. doi: 10.1007/s10096-020-04117-x. Epub 2021 Jan 6. Impact factor: 3.267 Publication type: Paper in international publication Authors: Escola-Verge, Laura, Fernandez-Hidalgo, Nuria, Fernandez-Galera, Ruben, Almirante, Benito, Larrosa, Maria Nieves et al. DOI: 10.1007/s10096-020-04117-x
PMID: 31819991 Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY Year: 2020 Reference: J Antimicrob Chemother. 2020 Mar 1;75(3):730-737. doi: 10.1093/jac/dkz491. Impact factor: 5.439 Publication type: Paper in international publication Authors: Grau, I, Munoz, Patricia, Aguilar-Guisado, Manuela, Puerta-Alcalde, Pedro, Tasias, Mariona, Ruiz-Gaitan, Alba, Gonzalez, Fernando, Puig-Asensio, Mireia, Vena, Antonio, Marco, Francesc et al. DOI: 10.1093/jac/dkz491
PMID: 32056418 Journal: Revista Espanola de Quimioterapia Year: 2020 Reference: Rev Esp Quimioter. 2020 Apr;33(2):110-115. doi: 10.37201/req/094.2019. Epub 2020 Feb 14. Impact factor: 1.132 Publication type: Paper in international publication Authors: Rubio, V, Solano, C, Vazquez, L, Ruiz, I, Serrano, D, Lopez-Jimenez, J, Valcarcel, D, Lopez-Sanchez, C, Gomez, V et al. DOI: 10.37201/req/094.2019
PMID: 31843689 Journal: JOURNAL OF INFECTION Year: 2020 Reference: J Infect. 2020 Feb;80(2):190-196. doi: 10.1016/j.jinf.2019.12.006. Epub 2019 Dec 13. Impact factor: 4.842 Publication type: Paper in international publication Authors: Ferrer, Ricard, Nuvials, Xavier, Deu, Maria, Peghin, Maddalena, Gonzalez-Lopez, Juan Jose, Lung, Mayli, Roman, Antonio, Gavalda, Joan, Len, Oscar, Berastegui, Cristina et al. DOI: 10.1016/j.jinf.2019.12.006
PMID: 32015035 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2020 Reference: Antimicrob Agents Chemother. 2020 Mar 24;64(4). pii: AAC.02494-19. doi: 10.1128/AAC.02494-19. Print 2020 Mar 24. Impact factor: 4.904 Publication type: Paper in international publication Authors: Gudiol, C, Albasanz-Puig, A, Laporte-Amargos, J, Pallares, N, Mussetti, A, Ruiz-Camps, I, Puerta-Alcalde, P, Abdala, E, Oltolini, C, Akova, M et al. DOI: 10.1128/AAC.02494-19
PMID: 30738196 Journal: Travel Medicine and Infectious Disease Year: 2019 Reference: Travel Med Infect Dis. 2019 May - Jun;29:51-57. doi: 10.1016/j.tmaid.2019.02.001. Epub 2019 Feb 6. Impact factor: 4.868 Publication type: Paper in international publication Authors: Molina, Israel, Henriquez-Camacho, Cesar, Serre, Nuria, Norman, Francesca, Wilkman-Jorgensen, Philip, Torrus, Diego, Ramos Rincon, Jose Manuel, Malmierca, Eduardo, Perez-Ayala, Ana, Herrero, Juan Maria et al. DOI: 10.1016/j.tmaid.2019.02.001
PMID: 30722752 Journal: INTERNATIONAL JOURNAL OF STD & AIDS Year: 2019 Reference: Int J STD AIDS. 2019 May;30(6):623-625. doi: 10.1177/0956462419825896. Epub 2019 Feb 5. Impact factor: 1.501 Publication type: Paper in international publication Authors: Isabel Lazaro-Simo, Anna, Esperalba-Esquerra, Juliana, Vall-Mayans, Marti et al. DOI: 10.1177/0956462419825896
PMID: 30723941 Journal: PHARMACOTHERAPY Year: 2019 Reference: Pharmacotherapy. 2019 Apr;39(4):501-507. doi: 10.1002/phar.2227. Epub 2019 Mar 22. Impact factor: 3.045 Publication type: Paper in international publication Authors: Navarro, Jordi, Santos, Jose Ramon, Silva, Ana, Burgos, Joaquin, Falco, Vicenc, Ribera, Esteban, Imaz, Arkaitz, Curran, Adrian et al. DOI: 10.1002/phar.2227
PMID: 30587519 Journal: NEUROLOGY Year: 2019 Reference: Neurology. 2019 Feb 5;92(6):296-298. doi: 10.1212/WNL.0000000000006801. Epub 2018 Dec 26. Impact factor: 8.689 Publication type: Paper in international publication Authors: Pappolla, Agustin, Midaglia, Luciana, Boix Rodriguez, Claudia P, Puig, Adaia Albasanz, Lung, Maiylyi, Camps, Isabel Ruiz, Castillo, Joaquin, Mulero, Patricia, Arrambide, Georgina, Rodriguez-Acevedo, Breogan et al. DOI: 10.1212/WNL.0000000000006801
The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.
